United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2006_register
executive
2010-09-22
article
Prospective Grant of Exclusive License: Prophylactic Use of Pneumococcal Surface Adhesin A Protein as a Vaccine
Notices
D09002ee1bde0c2ee
D09002ee1bde0c39d
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
United States
Centers for Disease Control and Prevention
originator
org
United States Government Agency or Subagency
This is a notice in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i) that the Centers for Disease Control and Prevention (CDC), Technology Transfer Office, Department of Health and Human Services (DHHS), is contemplating the grant of a worldwide, limited field of use, exclusive license to practice the inventions embodied in the patent and patent applications referred to below to Intercell, having a place of business in Vienna, Austria. The patent rights in these inventions have been assigned to the government of the United States of America. The patent and patent applications to the licensed are: U.S. Patent No. 5,422,427 entitled ``Pneumococcal Fimbrial Protein A,'' issued 06.06.95.
71 FR 51624
https://www.govinfo.gov/app/details/FR-2006-08-30/E6-14423
E6-14423
fr30au06-119
4163-18-P
https://www.govinfo.gov/app/details/FR-2006-08-30/E6-14423
https://www.govinfo.gov/content/pkg/FR-2006-08-30/html/E6-14423.htm
https://www.govinfo.gov/content/pkg/FR-2006-08-30/pdf/E6-14423.pdf
2 p.
51624
51625
71 FR 51624
Prospective Grant of Exclusive License: Prophylactic Use of Pneumococcal Surface Adhesin A Protein as a Vaccine; Federal Register Vol. 71, Issue
NOTICE
E6-14423
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
4163-18-P
E6-14423
Notice.
This is a notice in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i) that the Centers for Disease Control and Prevention (CDC), Technology Transfer Office, Department of Health and Human Services (DHHS), is contemplating the grant of a worldwide, limited field of use, exclusive license to practice the inventions embodied in the patent and patent applications referred to below to Intercell, having a place of business in Vienna, Austria. The patent rights in these inventions have been assigned to the government of the United States of America. The patent and patent applications to the licensed are: U.S. Patent No. 5,422,427 entitled ``Pneumococcal Fimbrial Protein A,'' issued 06.06.95.
Patent licenses; non-exclusive, exclusive, or partially exclusive:
Intercell,
Federal Register
Vol. 71, no. 168
Office of the Federal Register, National Archives and Records Administration
2006-08-30
continuing
daily
deposited
born digital
304 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2006-08-30
P0b002ee180966672
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr30au06
https://www.govinfo.gov/app/details/FR-2006-08-30
https://www.govinfo.gov/content/pkg/FR-2006-08-30/pdf/FR-2006-08-30.pdf
https://www.govinfo.gov/content/pkg/FR-2006-08-30/xml/FR-2006-08-30.xml
fdlp
51421
51712
DGPO
2010-09-22
2023-05-03
FR-2006-08-30
machine generated
eng
FR
FR-2006-08-30
71
168